A multicenter prospective study to evaluate the efficacy of resection for initially unresectable hepatocellular carcinoma after atezolizumab combined with bevacizumab (the RACB study): Short-term ...
Unfortunately, even with the use of US contrast agents, there is considerable overlap in the appearance of metastases and hepatocellular carcinoma (HCC). [21] On a case-by-case basis, clinical and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback